Related Experiment Video
Updated: Aug 21, 2026
Imaging the Human Immunological Synapse
Published on: December 26, 2019
Modeling of receptor mimics that inhibit superantigen pathogenesis
Margit Möllhoff1, Hannah B Vander Zanden, Patrick R Shiflett
1Biosciences Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
Abstract:
Staphylococcal enterotoxins SEB and SEC3 and toxic shock syndrome toxin TSST-1 act as superantigens by overstimulating the human immune system and thereby compromise host defense. The mechanism of pathogenesis is explained on the basis of superantigen binding to the MHC class II receptor on the antigen presenting cell and to the T cell receptor (TcR) on the T cell. SEB, SEC3 and TSST-1 bind as intact proteins and make contacts with the alpha1 subdomain (DRalpha) of MHC class II and Vbeta subdomain of TcR. SEB, SEC3 and TSST-1 show specificities for different TcRVbeta isoforms. We have designed three different chimeras linking the same DRalpha with different TcRVbeta isoforms to specifically target SEB, SEC3 and TSST-1 and inhibit their pathogenesis. Here, we show by molecular modeling that the DRalpha, TcRVbeta and linker of a given chimera interact with the target superantigen in a type-specific manner. An initial model of the complex is constructed on the basis of observed inter-molecular contacts between DRalpha/TcRVbeta and the superantigens. A constant temperature (300 K) 200 ps molecular dynamics is performed to sample different conformations of a chimera-superantigen complex by utilizing the flexibility of the (GSTAPPA)(2) linker while maintaining the native folds of superantigen, DRalpha and TcRVbeta and the observed intermolecular contacts. After equilibration, 100 molecular dynamic snapshots are minimized and analyzed. This provides descriptions of various pairwise interactions at the contact interface in the complex and important clues on single site mutations on the chimera that may enhance the stability of a given superantigen-chimera complex.
Insights
Staphylococcal superantigens like SEB, SEC3, and TSST-1 overstimulate the immune system. Molecular modeling of novel chimeras targeting these superantigens shows type-specific interactions, offering potential therapeutic strategies.
Area of Science:
- Immunology
- Molecular Biology
- Computational Chemistry
Background:
- Staphylococcal enterotoxins (SEB, SEC3) and toxic shock syndrome toxin (TSST-1) are superantigens that hyperactivate the immune system, compromising host defense.
- Superantigen pathogenesis involves binding to MHC class II on antigen-presenting cells and the T cell receptor (TcR) on T cells.
Purpose of the Study:
- To design and computationally model novel chimeric molecules targeting specific staphylococcal superantigens (SEB, SEC3, TSST-1).
- To investigate the type-specific interactions between designed DRalpha-TcRVbeta chimeras and target superantigens.
- To identify potential mutations for enhancing chimera-superantigen complex stability.
Main Methods:
- Molecular modeling and simulation techniques, including molecular dynamics (MD) at constant temperature (300 K) for 200 ps.
- Analysis of intermolecular contacts and pairwise interactions at the chimera-superantigen complex interface.
- Utilizing a flexible (GSTAPPA)2 linker to sample conformations while preserving native folds.
Main Results:
- Molecular modeling confirmed type-specific interactions between DRalpha, TcRVbeta, and linker components of the chimeras with their target superantigens.
- The study elucidated pairwise interactions at the contact interface of the chimera-superantigen complex.
- Identified potential single-site mutations on the chimera to improve complex stability.
Conclusions:
- Designed DRalpha-TcRVbeta chimeras exhibit type-specific binding to staphylococcal superantigens SEB, SEC3, and TSST-1.
- Computational analysis provides a basis for rational design of inhibitors to neutralize superantigen activity.
- This approach offers a promising strategy for developing therapeutics against superantigen-mediated diseases.
Related Concept Videos
01:29The Two-State Receptor Model
The binding affinity of a drug determines its interaction with one...
01:15Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...